Human Biospecimen Solutions
Accelerate precision oncology with Crown Bioscience’s high-quality human biospecimens—comprehensive, clinically annotated samples including tumor tissue, plasma, and PBMCs, optimized for multi-omics research and biomarker discovery.
Receive your quote directly from the manufacturer.
Advancing Precision Oncology Through High-Quality Human Biospecimens
In the pursuit of breakthroughs in cancer research, access to high-quality, well-annotated human biospecimens is paramount. Crown Bioscience offers an extensive biobank designed to meet the rigorous demands of modern oncology research, providing a diverse array of samples coupled with rich clinical data to facilitate comprehensive studies and accelerate discoveries.
Comprehensive Biospecimen Inventory
Crown Bioscience’s biobank encompasses a wide variety of human biospecimens, including:
- Tumor and Adjacent Normal Tissue: Preserved with ultra-short ischemia times to maintain molecular integrity, these samples are ideal for genomic, transcriptomic, and proteomic analyses.
- Plasma and Serum: Suitable for biomarker discovery and validation, these samples support studies in circulating tumor DNA (ctDNA) and other soluble factors.
- Peripheral Blood Mononuclear Cells (PBMCs): Essential for immunological assays and understanding the immune landscape in cancer patients.
Each sample is meticulously collected following standardized protocols to ensure consistency and reliability across studies.
Rich Clinical Annotation
Beyond the physical samples, each biospecimen is accompanied by comprehensive clinical data, including:
- Patient Demographics and Medical History: Providing context for disease progression and treatment response.
- Therapeutic Regimens and Outcomes: Enabling correlation between molecular findings and clinical efficacy.
- Biomarker Status and Genetic Mutations: Facilitating targeted therapy research and personalized medicine approaches.
This depth of information allows researchers to draw meaningful connections between molecular data and clinical outcomes, enhancing the translational value of their studies.
Global Collection Network
Leveraging a global clinical network spanning Europe, the USA, and Asia, Crown Bioscience ensures a diverse and representative sample population. This international reach supports studies aiming to understand cancer across different demographics and genetic backgrounds, broadening the applicability of research findings.
Applications in Oncology Research
The high-quality biospecimens and associated data support a multitude of research applications, including:
- Multi-Omics Studies: Integrating genomic, transcriptomic, proteomic, and metabolomic data to uncover complex biological insights.
- Biomarker Discovery and Validation: Identifying novel biomarkers for early detection, prognosis, and therapeutic targeting.
- Drug Development and Efficacy Testing: Assessing the impact of new compounds on human-derived tissues to predict clinical outcomes.
- Immuno-Oncology Research: Exploring immune responses and developing immunotherapies using PBMCs and other immune-related samples.
